Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1422350 | 0.84 | ALDH1A1 (0.44) | ALDH1A1TDP1FFAR3TSHRKDM4E | |
| SCHEMBL36528 | 0.84 | — | — | |
| SCHEMBL11357472 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1TRPA1KDM4EATM | |
| SCHEMBL11450692 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TDP1TRPA1KDM4EATM | |
| SCHEMBL9577628 | 0.82 | GAA (0.39) | ALDH1A1TDP1TRPA1TSHRKDM4E | |
| SCHEMBL10395982 | 0.81 | ALDH1A1 (0.43) | ALDH1A1TDP1FFAR3TSHRKDM4E | |
| SCHEMBL10400342 | 0.81 | — | — | |
| SCHEMBL28488745 | 0.81 | — | — | |
| Acetone SCHEMBL9445711 | 0.81 | LMNA (0.46) | ALDH1A1FFAR3TSHR | |
| Methane SCHEMBL28300736 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101553477-A | Process for preparation of aldonic acids and derivatives thereof | CB FLEET CO INC (US) | 2009-10-07 | — | — | CN | disclosed |
| EP-2089372-A2 | PROCESS FOR PREPARATION OF ALDONIC ACIDS AND DERIVATIVES THEREOF | C.B. Fleet Company Incorporated (US) | 2009-08-19 | — | — | EP | disclosed |
| US-20090112002-A1 | PROCESS FOR PREPARATION OF ALDONIC ACIDS AND DERIVATIVES THEREOF | APTALIS PHARMA CANADA INC. (CA) | 2009-04-30 | — | — | US | disclosed |
| WO-2008053206-A2 | PROCESS FOR PREPARATION OF ALDONIC ACIDS AND DERIVATIVES THEREOF | C.B. FLEET COMPANY, INC. (US) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112002-A1 | PROCESS FOR PREPARATION OF ALDONIC ACIDS AND DERIVATIVES THEREOF | ALDOA, ALG1, DERA | ALDH1A1 216/4885TDP1 4458/4885FFAR3 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.